Croda International Plc, who create, make and sell speciality chemicals, announced on 11 th that it has acquired Nautilus Biosciences Canada Inc (‘Nautilus’), a technology-rich marine biotechnology company based in Charlottetown, Prince Edward Island, Canada.
Nautilus was founded in 2007 by Professor Russell Kerr and, together with its other scientists, focuses on using marine microbial biodiversity to discover novel actives and materials. With the acquisition, that included associated patents, Croda will utilise this innovative science for applications across all its market sectors.
Croda and Nautilus already have worked in collaboration for the past six years developing specific applications for skin care and hair care, as well as crop care. Croda intends to establish Nautilus as a Croda Centre of Innovation for Marine Biotechnology at Nautilus’ existing base at the University of Prince Edward Island. This location is ideal for biotechnology research and has already attracted and facilitated partnerships with many other biotechnology-based companies.
“This is another clear example of how sustainable innovation is underpinning our growth plans. With Nautilus as part of the Croda Group, we further expand our expertise in biotechnology; the Nautilus team that will join us have extensive knowledge and expertise in marine biotechnology, also known as “blue biotechnology”. We will be able to bring new, patented products to market, alongside our already well-known green and white biotechnology ingredients, giving us the full spectrum of capabilities within this field of science.”
Professor Russell Kerr, Founder of Nautilus, has recognised the very positive and collaborative relationship he has with both Croda and the University of Prince Edward Island: “Becoming part of the Croda group will provide Nautilus the resources and support to establish a key centre for the research and development of marine-derived natural products, as well as providing Croda new products for commercial success,” he said.